Samarkand Group plc (SMK)
15 August 2022
Samarkand Group plc
("Samarkand", the "Company" or together with its subsidiaries the "Group")
Deferred Consideration payment in relation to the Napiers the Herbalist acquisition
Samarkand Group plc, the cross-border eCommerce technology, services and consumer brand group, announces today the payment of the deferred consideration in relation to the Napiers the Herbalist acquisition, first announced on 2 November 2021.
The deferred consideration payment of
Application has been made to the Aquis Stock Exchange for the admission to trading on the Aquis Stock Exchange Growth Market ("Admission") of the 45,802 New Ordinary Shares in the capital of the Company. The New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares and Admission is expected to become effective on 18 August 2022.
Total Voting Rights
Following Admission of the 45,802 New Ordinary Shares on 18 August 2022, the Company’s enlarged issued share capital will comprise of 54,760,585 ordinary shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
For more information, please contact:
Notes to Editors
Samarkand is a cross-border eCommerce technology and retail group focusing on connecting International Brands with
Founded in 2016, Samarkand is headquartered in
For further information please visit https://www.samarkand.global/
|EQS News ID:||1419931|
|End of Announcement||EQS News Service|